CDC surveillance report tracks multisystem inflammatory syndrome in children during COVID-19 pandemic

The Centers for Disease Control and Prevention (CDC) published a surveillance report in the Notes from the Field series tracking multisystem inflammatory syndrome in children (MIS-C) in the United States. The report describes changes in MIS-C cases among children since early in the COVID-19 pandemic. No specific data on case numbers, demographic characteristics, geographic distribution, or temporal trends are reported in the available summary.

No intervention, exposure, comparator, or specific outcomes are detailed. The report's methodology, sample size, and follow-up duration are not reported. Safety information, including adverse events or tolerability, is also not provided.

Key limitations include the absence of quantitative data and the descriptive nature of the report. Funding sources and potential conflicts of interest are not reported. The practice relevance is not specified, and no causal inferences can be drawn from this surveillance summary.

This report serves as a reminder of ongoing public health monitoring for MIS-C. Clinicians should consult the full CDC report and subsequent data releases for specific epidemiological findings. Continued vigilance for this condition in pediatric patients remains warranted.